Samlyn Capital’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-84,100
| Closed | -$10.2M | – | 137 |
|
|
2017
Q2 | $10.2M | Buy |
84,100
+34,800
| +71% | +$4.23M | 0.25% | 69 |
|
|
2017
Q1 | $5.98M | Buy |
49,300
+15,300
| +45% | +$1.85M | 0.14% | 99 |
|
|
2016
Q4 | $4.16M | Buy |
+34,000
| New | +$4.16M | 0.09% | 99 |
|
|
2014
Q3 | – | Sell |
-129,000
| Closed | -$20.2M | – | 98 |
|
|
2014
Q2 | $20.2M | Buy |
129,000
+2,400
| +2% | +$375K | 0.46% | 67 |
|
|
2014
Q1 | $19.3M | Sell |
126,600
-158,100
| -56% | -$24.1M | 0.45% | 72 |
|
|
2013
Q4 | $37.8M | Buy |
+284,700
| New | +$37.8M | 0.95% | 44 |
|